Xuzhou Xinhang Footwear Co., Ltd. – Trademark Portfolio
Entity Type: 16
Xuzhou Xinhang Footwear Co., Ltd. has 6 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 5 are successfully registered — a 100% registration rate, with 1 application currently pending. The portfolio includes marks such as MDCGFOD. Filings span 6 Nice Classification classes, with the highest activity in Class 25 (Clothing) and Class 24 (Fabrics). This trademark owner is based in Suining County.
No. 145-1,
Liji Town Industrial Park,
Suining County 221200 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xuzhou Xinhang Footwear Co., Ltd.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Xuzhou Xinhang Footwear Co., Ltd. have?
Xuzhou Xinhang Footwear Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending.
What trademark classes does Xuzhou Xinhang Footwear Co., Ltd. file in?
Xuzhou Xinhang Footwear Co., Ltd. files trademarks across 6 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 24 (Fabrics), Class 21 (Housewares), Class 16 (Paper Goods), Class 34 (Smokers Articles). Class 25 covers clothing, footwear, headgear.
What are Xuzhou Xinhang Footwear Co., Ltd.'s most well-known trademarks?
Xuzhou Xinhang Footwear Co., Ltd.'s registered trademark portfolio includes well-known marks such as MDCGFOD. These are among 5 currently registered trademarks in the portfolio.
What is Xuzhou Xinhang Footwear Co., Ltd.'s trademark registration success rate?
Xuzhou Xinhang Footwear Co., Ltd. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.